分析標準市場 – 2030年までの世界予測

Analytical Standards Market - Global Forecast to 2030

分析標準市場 - 技術 (GC、LC、TLC、IR、MS、NMR、滴定法)、カテゴリ (有機、無機)、方法 (生体分析、溶解)、用途 (食品・飲料、環境、製薬、臨床診断、法医学)、地域別 - 2030年までの世界予測
Analytical Standards Market by Technique (GC, LC, TLC, IR, MS, NMR, Titrimetry), Category (Organic, Inorganic), Method (Bioanalytical, Dissolution), Application (F&B, Environmental, Pharma, Clinical Diagnostic, Forensics), Region - Global Forecast to 2030

商品番号 : SMB-45500

出版社MarketsandMarkets
出版年月2025年3月
ページ数410
図表数478
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

Report Overview

The global analytical standards market is projected to reach USD 1.53 billion in 2024 to USD 2.16 billion by 2030, at a CAGR of 5.9% during the forecast period. The growing applications of analytical techniques in proteomics & metabolomics is one of the major factors anticipated to boost market growth in the forecasting years. Additionally, rising regulatory emphasis in pharmaceutical industry affects the growth of the analytical standards market.

世界の分析標準市場は、予測期間中に5.9%のCAGRで成長し、2024年には15億3,000万米ドル、2030年には21億6,000万米ドルに達すると予測されています。プロテオミクスとメタボロミクスにおける分析技術の応用拡大は、予測期間中に市場の成長を後押しすると予想される主な要因の1つです。さらに、製薬業界における規制強化も分析標準市場の成長に影響を与えています。

分析標準市場 - 2030年までの世界予測
analytical-standards-market-Overview

“The contact-based analytical standards segment to hold the largest share of the market in 2024.”

Based on category, analytical standards is segmented into organic standards and inorganic standards. The organic standards segment is expected to dominate the analytical standards market during the forecast period. With the rising number of clinical trials, the increasing focus on drug discovery & development, strict regulatory emphasis on effective pollution monitoring & control, and increasing public-private investments for R&D activities leads to the growth of this market segment.

“The external beam analytical standards procedures segment to hold the largest share of the market in 2024.”

Based on technique, the analytical standards market is segmented into chromatography, spectroscopy, titrimetry, and physical properties testing. The analytical standards market is expected to be dominated by spectroscopy segment during the forecast period. The spectroscopy segment is further segmented into atomic absorption spectroscopy, mass spectroscopy, IR spectroscopy, nuclear magnetic resonance spectroscopy, UV/Vis spectroscopy and X-ray fluorescence/diffraction spectroscopy. The spectroscopy are expected to grow due to the widespread use of spectroscopic techniques across a broad range of application areas such as forensic, biotech, and material science and rising technological advancements for the improvement of sensitivity and resolution.

“The raw material testing segment to hold the largest share of the market in 2024.”

The methodology market is segmented into raw material testing, bioanalytical testing, stability testing, dissolution testing, and other methodologies. Raw material testing accounted for the largest share of the global analytical standards market during the forecasted years. This can be attributed to the rising disease prevalence and the increase in commercialization of parenteral drugs.

分析標準市場 - 2030年までの世界予測 region
analytical-standards-market-Region

“The market in the APAC region is expected to register highest growth rate for analytical standards in 2024.”

The analytical standards market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, a significant market share for analytical standards was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. The increasing market penetration opportunities in emerging APAC countries led to the growth of the analytical standards market in this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1– 49%, Tier 2– 31%, and Tier 3– 20%
  • By Designation: Directors– 19%, C-level– 28%, and Others– 53%
  • By Region: North America– 31%, Europe– 33%, Asia Pacific– 19%, Latin America- 10%, MEA- 7%

The prominent players in the Analytical standards market are Merck KGaA (Germany), Agilent Technologies, Inc. (US), Waters Corporation (US), LGC Limited (UK), PerkinElmer (US), Restek Corporation (US), SPEX CertiPrep (US), AccuStandard (US), Thermo Fisher Scientific, Inc. (US), Mallinckrodt (UK), The United States Pharmacopeial Convention (US), Cayman Chemical (US), RICCA Chemical Company (US) and GFS Chemicals, Inc. (US), among others.

分析標準市場 - 2030年までの世界予測 ecosystem
analytical-standards-market-Ecosystem

Research Coverage

This report studies the analytical standards market based on technique, application, category, methodology, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers (Stringent regulatory guidelines in pharmaceutical industry, Rising public concerns regarding food safety & quality, Increasing public-private investments in research, Growing applications of analytical techniques in proteomics & metabolomics, Rising regulatory emphasis on pollution control, Growth in pharmaceutical & biotechnology industries, Increasing adoption of analytical techniques in pesticide monitoring), restraints (Limited public awareness of pollution monitoring strategies in emerging economies, Stringent storage requirements for analytical standards), opportunities (Development of new drugs adhering to GMP regulations, Increasing number of clinical trials), and challenges (Inadequate standards for analytical techniques, Shortage of skilled laboratory technicians) influencing the growth of the analytical standards market
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the analytical standards market
  • Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and analytical developments in the analytical standards market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the analytical standards market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players.

Table of Contents

1              INTRODUCTION       36

1.1           STUDY OBJECTIVES 36

1.2           MARKET DEFINITION               36

1.3           MARKET SCOPE       37

1.3.1        MARKETS COVERED                37

1.3.2        INCLUSIONS & EXCLUSIONS   38

1.3.3        REGIONS COVERED 38

1.3.4        YEARS CONSIDERED               39

1.3.5        CURRENCY CONSIDERED        39

1.4           MARKET STAKEHOLDERS       39

1.5           SUMMARY OF CHANGES         40

2              RESEARCH METHODOLOGY    41

2.1           RESEARCH DATA     41

2.1.1        SECONDARY DATA  42

2.1.1.1    List of secondary sources        43

2.1.2        PRIMARY DATA        44

2.1.2.1    Key data from primary sources                44

2.1.2.2    Objectives of primary research                45

2.2           MARKET ESTIMATION METHODOLOGY   46

2.2.1        REVENUE MAPPING-BASED MARKET ESTIMATION 47

2.2.1.1    Segmental revenue share analysis         48

2.2.2        USAGE-BASED MARKET ESTIMATION     49

2.2.3        TOP-DOWN APPROACH            50

2.2.4        VOLUME DATA ANALYSIS         51

2.2.5        PRIMARY RESEARCH VALIDATION           52

2.3           DATA TRIANGULATION             53

2.4           STUDY ASSUMPTIONS             54

2.5           RESEARCH LIMITATIONS         54

2.6           RISK ASSESSMENT 55

3              EXECUTIVE SUMMARY             56

4              PREMIUM INSIGHTS                60

4.1           ANALYTICAL STANDARDS MARKET OVERVIEW       60

4.2           EUROPE: ANALYTICAL STANDARDS MARKET, BY APPLICATION AND REGION (2023)       62

4.3           ANALYTICAL STANDARDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES      63

4.4           ANALYTICAL STANDARDS MARKET: REGIONAL MIX, 2022–2030 (USD MILLION) 63

5              MARKET OVERVIEW 64

5.1           INTRODUCTION       64

5.2           MARKET DYNAMICS                 64

5.2.1        DRIVERS  65

5.2.1.1    Stringent regulatory guidelines in pharmaceutical industry   65

5.2.1.2    Rising public concerns regarding food safety & quality          65

5.2.1.3    Increasing public-private investments in research 66

5.2.1.4    Growing applications of analytical techniques in proteomics & metabolomics          67

5.2.1.5    Rising regulatory emphasis on pollution control     68

5.2.1.6    Growth in pharmaceutical & biotechnology industries            68

5.2.1.7    Increasing adoption of analytical techniques in pesticide monitoring                 69

5.2.2        RESTRAINTS            70

5.2.2.1    Limited public awareness of pollution monitoring strategies in emerging economies                70

5.2.2.2    Stringent storage requirements for analytical standards       70

5.2.3        OPPORTUNITIES      70

5.2.3.1    Development of new drugs adhering to GMP regulations      70

5.2.3.2    Increasing number of clinical trials         71

5.2.4        CHALLENGES           72

5.2.4.1    Inadequate standards for analytical techniques     72

5.2.4.2    Shortage of skilled laboratory technicians              73

5.3           REGULATORY SCENARIO         74

5.3.1        REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS      74

5.3.2        REGULATORY FRAMEWORK    76

5.3.2.1    North America         76

5.3.2.1.1 US            76

5.3.2.1.2 Canada   77

5.3.2.2    Europe     77

5.3.2.3    Asia Pacific              78

5.3.2.3.1 China       78

5.3.2.3.2 Japan      78

5.3.2.3.3 India        78

5.3.2.4    Latin America          79

5.3.2.4.1 Brazil       79

5.3.2.4.2 Mexico     79

5.3.2.5    Middle East              79

5.3.2.6    Africa       79

5.4           VALUE CHAIN ANALYSIS          80

5.4.1        RESEARCH & DEVELOPMENT 80

5.4.2        RAW MATERIAL PROCUREMENT & MANUFACTURING             80

5.4.3        DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES                 80

5.5           SUPPLY CHAIN ANALYSIS        82

5.5.1        PROMINENT COMPANIES        82

5.5.2        SMALL & MEDIUM-SIZED ENTERPRISES 82

5.5.3        DISTRIBUTORS        82

5.5.4        END USERS              82

5.6           ECOSYSTEM ANALYSIS            83

5.7           PORTER’S FIVE FORCES ANALYSIS          85

5.7.1        INTENSITY OF COMPETITIVE RIVALRY     86

5.7.2        BARGAINING POWER OF SUPPLIERS       86

5.7.3        BARGAINING POWER OF BUYERS            86

5.7.4        THREAT OF SUBSTITUTES        86

5.7.5        THREAT OF NEW ENTRANTS   87

5.8           KEY STAKEHOLDERS & BUYING CRITERIA              87

5.8.1        KEY STAKEHOLDERS IN BUYING PROCESS             87

5.8.2        KEY BUYING CRITERIA             88

5.9           TRADE ANALYSIS     89

5.9.1        IMPORT DATA HS CODE 293499            89

5.9.2        EXPORT DATA HS CODE 293499            89

5.10         PATENT ANALYSIS   90

5.10.1     LIST OF MAJOR PATENTS        91

5.11         PRICING ANALYSIS  91

5.11.1     AVERAGE SELLING PRICE OF ANALYTICAL STANDARDS, BY APPLICATION (2024)               92

5.11.2     AVERAGE SELLING PRICE OF ANALYTICAL STANDARDS, BY KEY PLAYER (2024)     93

5.11.3     AVERAGE SELLING PRICE TREND OF ANALYTICAL STANDARDS, BY REGION (2022−2024)            94

5.12         TECHNOLOGY ANALYSIS          96

5.12.1     KEY TECHNOLOGIES                96

5.12.1.1  Chromatography     96

5.12.1.2  Spectroscopy           96

5.12.1.3  Physical property testing         96

5.12.1.4  Titration   96

5.12.2     COMPLEMENTARY TECHNOLOGIES        97

5.12.2.1  Data analysis technologies      97

5.12.2.2  Imaging & microscopy technologies        97

5.12.2.3  Automation & control systems                 97

5.12.3     ADJACENT TECHNOLOGIES     97

5.12.3.1  Molecular diagnostics              97

5.12.3.2  Process Analytical Technology (PAT)       98

5.13         KEY CONFERENCES & EVENTS, 2025–2026         98

5.14         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES                 99

5.15         INVESTMENT & FUNDING SCENARIO      100

5.16         UNMET NEEDS        101

5.17         IMPACT OF AI/GENERATIVE AI ON ANALYTICAL STANDARDS MARKET                 102

6              ANALYTICAL STANDARDS MARKET, BY TECHNIQUE                104

6.1           INTRODUCTION       105

6.2           SPECTROSCOPY      105

6.2.1        MASS SPECTROSCOPY            110

6.2.1.1    Increasing research focus on multiple molecules and specific metabolites to drive market    110

6.2.2        ATOMIC ABSORPTION SPECTROSCOPY   110

6.2.2.1    High-throughput capabilities to fuel uptake            110

6.2.3        UV/VISIBLE SPECTROSCOPY   111

6.2.3.1    Rapid analytical responses and ease of use to drive market 111

6.2.4        X-RAY FLUORESCENCE/DIFFRACTION SPECTROSCOPY          112

6.2.4.1    Low cost of sample preparation to support market growth    112

6.2.5        IR SPECTROSCOPY  112

6.2.5.1    High adoption among researchers & scientists to fuel market                 112

6.2.6        NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY               113

6.2.6.1    Advantages of high speed & accuracy to boost demand        113

6.2.7        OTHER SPECTROSCOPY STANDARDS     114

6.3           CHROMATOGRAPHY                114

6.3.1        ION CHROMATOGRAPHY         119

6.3.1.1    Multiple ion analysis for organic acids & anions to drive market                 119

6.3.2        GAS CHROMATOGRAPHY        120

6.3.2.1    High stability & sensitivity features to fuel uptake  120

6.3.3        LIQUID CHROMATOGRAPHY    120

6.3.3.1    High automation and versatility to support market growth     120

6.3.4        THIN-LAYER CHROMATOGRAPHY            121

6.3.4.1    Rapid analysis time and low solvent consumption to support market growth     121

6.3.5        OTHER CHROMATOGRAPHY STANDARDS                122

6.4           TITRIMETRY             122

6.4.1        UTILIZATION IN QUANTITATIVE CHEMICAL ANALYSIS FOR PHARMACEUTICAL APPLICATIONS TO PROPEL MARKET         122

6.5           PHYSICAL PROPERTY TESTING                126

6.5.1        VISCOSITY TESTING 131

6.5.1.1    Stringent regulations for assessing F&B testing quality to drive market                 131

6.5.2        SIEVE CALIBRATION & PARTICLE SIZE TESTING      131

6.5.2.1    Increasing research activities in nanotechnology to fuel market                 131

6.5.3        COLOR REFERENCE TESTING 132

6.5.3.1    Rising production of petrochemical products to support market growth                 132

6.5.4        OTHER PHYSICAL PROPERTY TESTING STANDARDS               133

7              ANALYTICAL STANDARDS MARKET, BY APPLICATION             134

7.1           INTRODUCTION       135

7.2           PHARMACEUTICAL & LIFE SCIENCE STANDARDS   136

7.2.1        PHARMACOPOEIA STANDARDS               139

7.2.1.1    Presence of stringent regulations for drug approval processes to fuel market     139

7.2.2        PHARMACEUTICAL IMPURITY REFERENCE STANDARDS         139

7.2.2.1    Ability to analyze, identify, and quantify drug impurities to drive market                 139

7.2.3        PHARMACEUTICAL SECONDARY STANDARDS         140

7.2.3.1    Growing need for high-quality raw materials to drive market 140

7.2.4        HERBAL DRUG/PHYTOPHARMACEUTICAL STANDARDS          141

7.2.4.1    Detection of contaminants to fuel uptake               141

7.2.5        COSMETIC STANDARDS           142

7.2.5.1    Identification of hazardous ingredients in cosmetic products to boost demand   142

7.2.6        FLUORESCENT MICROPARTICLE STANDARDS        143

7.2.6.1    Broadening applications of flow cytometry and elemental analysis to fuel uptake              143

7.3           FOOD & BEVERAGE STANDARDS             144

7.3.1        PEPTIDE/AMINO ACID STANDARDS        147

7.3.1.1    Determination of amino acid concentration & proteins to fuel uptake                 147

7.3.2        FLAVOR & FRAGRANCE STANDARDS      148

7.3.2.1    Growing need for enhanced trace-level detection to drive market                 148

7.3.3        MYCOTOXIN STANDARDS        149

7.3.3.1    Stringent regulations regarding mycotoxin concentration in edibles to drive market            149

7.3.4        CARBOHYDRATE STANDARDS 150

7.3.4.1    Increasing regulations for food safety & labeling to support market growth     150

7.3.5        FATTY ACID/LIPID STANDARDS               150

7.3.5.1    Qualitative & quantitative Identification of fatty acids to boost demand                 150

7.3.6        FOOD ADDITIVE STANDARDS  151

7.3.6.1    Rising need for food additive detection to propel market       151

7.3.7        PESTICIDE STANDARDS           152

7.3.7.1    Growth in organic & sustainable farming to drive segment    152

7.3.8        GMO STANDARDS   153

7.3.8.1    Rising focus on genetic engineering activities to fuel market 153

7.3.9        OTHER FOOD & BEVERAGE STANDARDS                 153

7.4           FORENSIC STANDARDS           154

7.4.1        DRUGS-OF-ABUSE STANDARDS               157

7.4.1.1    Detection of illegal drugs using chromatography & spectrometry techniques to fuel uptake       157

7.4.2        DOPING STANDARDS               157

7.4.2.1    Stringent anti-doping regulations to fuel market    157

7.4.3        OTHER FORENSIC STANDARDS               158

7.5           VETERINARY DRUG STANDARDS             159

7.5.1        ANTIBIOTIC STANDARDS          161

7.5.1.1    Analysis of antibiotics in animal food products with LC & MC techniques to boost demand     161

7.5.2        HORMONE STANDARDS          162

7.5.2.1    Growing consumer awareness regarding harmful veterinary hormones in food items to drive market  162

7.6           PETROCHEMICAL STANDARDS                163

7.6.1        GASOLINE, DIESEL, AND PETROLEUM STANDARDS                165

7.6.1.1    Rising need to curb air pollution to fuel uptake      165

7.6.2        BIOFUEL STANDARDS              166

7.6.2.1    Increasing focus on biofuel research to support market growth                 166

7.7           ENVIRONMENTAL STANDARDS                167

7.7.1        PESTICIDE STANDARDS           170

7.7.1.1    Detection of pesticides in drinking water and soil samples through LC-MS to fuel uptake    170

7.7.2        PFAS TESTING STANDARDS    170

7.7.2.1    Rising public health concerns for PFAS contamination to drive market                 170

7.7.3        MICROPLASTIC TESTING STANDARDS    171

7.7.3.1    Increasing concerns & growing awareness associated with microplastic contamination to support market growth                171

7.7.4        VOLATILE STANDARDS             172

7.7.4.1    Rising use in analytical labs for volatile compound quantification to support market growth            172

7.7.5        SEMI-VOLATILE STANDARDS   173

7.7.5.1    Mandatory semi-volatile testing for air pollutants to drive market                 173

7.7.6        AROCLOR/PCB AND DIOXIN STANDARDS                173

7.7.6.1    High environmental contamination of toxic industrial chemicals to fuel uptake     173

7.7.7        FLAME-RETARDANT STANDARDS            174

7.7.7.1    Growing focus on flame-retardant analysis in soil & wastewater to drive segment  174

7.7.8        OTHER ENVIRONMENTAL STANDARDS   175

7.8           CLINICAL DIAGNOSTICS STANDARDS      175

7.8.1        HORMONE TESTING STANDARDS            178

7.8.1.1    High production costs to restrict segment growth  178

7.8.2        VITAMIN STANDARDS              179

7.8.2.1    Rising demand for nutritional evaluation to drive market       179

7.8.3        BIOMARKER STANDARDS       180

7.8.3.1    Increasing focus on R&D activities for cancer and neurodegenerative disease to fuel market             180

7.8.4        CLINICAL TOXICOLOGY STANDARDS       180

7.8.4.1    Rising cases of drug toxicity to fuel uptake             180

7.8.5        OTHER CLINICAL DIAGNOSTICS STANDARDS          181

8              ANALYTICAL STANDARDS MARKET, BY METHODOLOGY         182

8.1           INTRODUCTION       183

8.2           RAW MATERIAL TESTING         183

8.2.1        RISING MANUFACTURING OF MEDICINAL & PETROCHEMICAL PRODUCTS TO DRIVE MARKET                183

8.3           STABILITY TESTING 186

8.3.1        INCREASING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET                 186

8.4           BIOANALYTICAL TESTING         188

8.4.1        GROWING FOCUS ON TESTING OF BIOLOGICS & BIOSIMILARS TO FUEL UPTAKE   188

8.5           DISSOLUTION TESTING            190

8.5.1        INCREASING PUBLIC-PRIVATE INVESTMENTS IN RESEARCH TO SUPPORT MARKET GROWTH  190

8.6           OTHER METHODOLOGIES       193

9              ANALYTICAL STANDARDS MARKET, BY CATEGORY 196

9.1           INTRODUCTION       197

9.2           ORGANIC STANDARDS             197

9.2.1        INCREASING FOCUS ON DRUG DEVELOPMENT AND CLINICAL TRIALS TO PROPEL MARKET    197

9.3           INORGANIC STANDARDS         200

9.3.1        INCREASING GOVERNMENT REGULATIONS ON PESTICIDE MONITORING & SOIL TESTING TO SUPPORT MARKET GROWTH             200

10            ANALYTICAL STANDARDS MARKET, BY REGION     204

10.1         INTRODUCTION       205

10.2         NORTH AMERICA     206

10.2.1     MACROECONOMIC OUTLOOK FOR NORTH AMERICA              206

10.2.2     US            214

10.2.2.1  Availability of public-private investments for life sciences research to fuel market              214

10.2.3     CANADA   217

10.2.3.1  Availability of government funding for research & innovation to drive market     217

10.3         EUROPE   219

10.3.1     MACROECONOMIC OUTLOOK FOR EUROPE            220

10.3.2     GERMANY                227

10.3.2.1  Growing focus on bioclusters and expansion of biotechnology sector to propel market          227

10.3.3     UK            230

10.3.3.1  Utilization of analytical techniques in food testing to drive market                 230

10.3.4     FRANCE   232

10.3.4.1  Established biotech hub to fuel uptake  232

10.3.5     ITALY        235

10.3.5.1  Growing focus on development of innovative molecules & therapies to boost demand         235

10.3.6     SPAIN       238

10.3.6.1  Rising demand for import of pharmaceutical products to fuel markets                 238

10.3.7     REST OF EUROPE    240

10.4         ASIA PACIFIC            243

10.4.1     MACROECONOMIC OUTLOOK FOR ASIA PACIFIC    243

10.4.2     JAPAN      252

10.4.2.1  Increasing utilization of advanced analytical technologies to propel market     252

10.4.3     CHINA      255

10.4.3.1  Rising incidence of infectious diseases and growing focus on stringent pharma guidelines to boost demand      255

10.4.4     INDIA       257

10.4.4.1  Increasing demand for soil & water testing to fuel market     257

10.4.5     AUSTRALIA               260

10.4.5.1  Rising focus on proteomics & metabolomics research to support market growth     260

10.4.6     SOUTH KOREA         262

10.4.6.1  Broadening applications for science research to propel market                 262

10.4.7     REST OF ASIA PACIFIC             264

10.5         LATIN AMERICA       267

10.5.1     MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 267

10.5.2     BRAZIL     274

10.5.2.1  Application of electrophoresis techniques in target disease treatments to fuel uptake          274

10.5.3     MEXICO   277

10.5.3.1  Public-private investments in the country’s healthcare system to support market growth            277

10.5.4     REST OF LATIN AMERICA         279

10.6         MIDDLE EAST & AFRICA          281

10.6.1     MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA   281

10.6.2     GCC COUNTRIES      288

10.6.2.1  Adoption of economic diversification strategies to drive market                 288

10.6.3     REST OF MIDDLE EAST & AFRICA            290

11            COMPETITIVE LANDSCAPE      293

11.1         INTRODUCTION       293

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN                293

11.2.1     OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANALYTICAL STANDARDS MARKET              294

11.3         REVENUE ANALYSIS, 2019–2023          295

11.4         MARKET SHARE ANALYSIS, 2023           295

11.4.1     ORGANIC ANALYTICAL STANDARDS MARKET RANKING         297

11.4.2     INORGANIC ANALYTICAL STANDARDS MARKET RANKING      298

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023           298

11.5.1     STARS      298

11.5.2     EMERGING LEADERS               299

11.5.3     PERVASIVE PLAYERS               299

11.5.4     PARTICIPANTS         299

11.5.5     COMPANY FOOTPRINT: KEY PLAYERS, 2023          301

11.5.5.1  Company footprint  301

11.5.5.2  Region footprint       302

11.5.5.3  Technique footprint 303

11.5.5.4  Application footprint                304

11.5.5.5  Methodology footprint             305

11.5.5.6  Category footprint   306

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023     307

11.6.1     PROGRESSIVE COMPANIES    307

11.6.2     RESPONSIVE COMPANIES       307

11.6.3     DYNAMIC COMPANIES             307

11.6.4     STARTING BLOCKS 307

11.6.5     COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023     309

11.6.5.1  Detailed list of key startups/SMEs          309

11.6.5.2  Competitive benchmarking of key emerging players/startups                 310

11.7         COMPANY VALUATION & FINANCIAL METRICS        311

11.7.1     COMPANY VALUATION             311

11.7.2     FINANCIAL METRICS                311

11.8         BRAND/PRODUCT COMPARISON            312

11.9         COMPETITIVE SCENARIO         313

11.9.1     PRODUCT LAUNCHES              313

11.9.2     DEALS      314

11.9.3     EXPANSIONS            314

12            COMPANY PROFILES                316

12.1         KEY PLAYERS           316

12.1.1     MERCK KGAA          316

12.1.1.1  Business overview   316

12.1.1.2  Products offered      317

12.1.1.3  Recent developments              320

12.1.1.3.1               Product launches    320

12.1.1.3.2               Deals       320

12.1.1.3.3               Expansions              320

12.1.1.4  MnM view                 321

12.1.1.4.1               Key strengths           321

12.1.1.4.2               Strategic choices     321

12.1.1.4.3               Weaknesses & competitive threats         321

12.1.2     THE UNITED STATES PHARMACOPEIAL CONVENTION             322

12.1.2.1  Business overview   322

12.1.2.2  Products offered      323

12.1.2.3  MnM view                 334

12.1.2.3.1               Key strengths           334

12.1.2.3.2               Strategic choices     335

12.1.2.3.3               Weaknesses & competitive threats         335

12.1.3     LGC LIMITED            336

12.1.3.1  Business overview   336

12.1.3.2  Products offered      337

12.1.3.3  Recent developments              338

12.1.3.3.1               Product launches    338

12.1.3.3.2               Deals       339

12.1.3.3.3               Expansions              339

12.1.3.4  MnM view                 340

12.1.3.4.1               Key strengths           340

12.1.3.4.2               Strategic choices     340

12.1.3.4.3               Weaknesses & competitive threats         340

12.1.4     AGILENT TECHNOLOGIES, INC.                341

12.1.4.1  Business overview   341

12.1.4.2  Products offered      342

12.1.4.3  Recent developments              349

12.1.4.3.1               Deals       349

12.1.4.3.2               Expansions              349

12.1.4.4  MnM view                 350

12.1.4.4.1               Key strengths           350

12.1.4.4.2               Strategic choices     350

12.1.4.4.3               Weaknesses & competitive threats         350

12.1.5     WATERS CORPORATION          351

12.1.5.1  Business overview   351

12.1.5.2  Products offered      352

12.1.5.3  Recent developments              355

12.1.5.3.1               Deals       355

12.1.5.4  MnM view                 355

12.1.5.4.1               Key strengths           355

12.1.5.4.2               Strategic choices     355

12.1.5.4.3               Weaknesses & competitive threats         356

12.1.6     THERMO FISHER SCIENTIFIC INC.           357

12.1.6.1  Business overview   357

12.1.6.2  Products offered      358

12.1.6.3  Recent developments              359

12.1.6.3.1               Expansions              359

12.1.7     MALLINCKRODT      360

12.1.7.1  Business overview   360

12.1.7.2  Products offered      362

12.1.8     PERKINELMER         363

12.1.8.1  Business overview   363

12.1.8.2  Products offered      363

12.1.9     RESTEK CORPORATION           364

12.1.9.1  Business overview   364

12.1.9.2  Products offered      364

12.1.9.3  Recent developments              367

12.1.9.3.1               Product launches    367

12.1.10   SPEX CERTIPREP     368

12.1.10.1                Business overview   368

12.1.10.2                Products offered      369

12.1.11   ACCUSTANDARD     371

12.1.11.1                Business overview   371

12.1.11.2                Products offered      371

12.1.11.3                Recent developments              372

12.1.11.3.1             Product launches    372

12.1.12   CAYMAN CHEMICAL 374

12.1.12.1                Business overview   374

12.1.12.2                Products offered      374

12.1.12.3                Recent developments              375

12.1.12.3.1             Deals       375

12.1.13   RICCA CHEMICAL COMPANY   376

12.1.13.1                Business overview   376

12.1.13.2                Products offered      376

12.1.14   GFS CHEMICALS, INC.             377

12.1.14.1                Business overview   377

12.1.14.2                Products offered      377

12.1.14.3                Recent developments              378

12.1.14.3.1             Deals       378

12.1.15   CHIRON AS (PART OF ANTYLIA SCIENTIFIC)             379

12.1.15.1                Business overview   379

12.1.15.2                Products offered      379

12.1.15.3                Recent developments              383

12.1.15.3.1             Product launches    383

12.1.15.3.2             Expansions              384

12.2         OTHER PLAYERS      385

12.2.1     CAMBRIDGE ISOTOPE LABORATORIES, INC.           385

12.2.2     REAGECON DIAGNOSTICS LTD.               387

12.2.3     CPI INTERNATIONAL                388

12.2.4     CRESCENT CHEMICAL CO., INC.              389

12.2.5     INORGANIC VENTURES            390

12.2.6     ALFA CHEMISTRY    391

12.2.7     BIOSYNTH                394

12.2.8     HPC STANDARDS GMBH         395

12.2.9     TOKYO CHEMICAL INDUSTRY CO., LTD.  396

12.2.10   SIMSON PHARMA LIMITED      397

12.2.11   NOVACHEM              398

12.2.12   LABSERT 399

12.2.13   WELLINGTON LABORATORIES INC.         400

13            APPENDIX                 401

13.1         DISCUSSION GUIDE 401

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                 406

13.3         CUSTOMIZATION OPTIONS      408

13.4         RELATED REPORTS 408

13.5         AUTHOR DETAILS    409

LIST OF TABLES

TABLE 1   ANALYTICAL STANDARDS MARKET: LIST OF SECONDARY SOURCES                 43

TABLE 2   ANALYTICAL STANDARDS MARKET: RISK ASSESSMENT         55

TABLE 3   DRUGS THAT LOST PATENT PROTECTION, 2023    71

TABLE 4   DRUGS THAT LOST PATENT PROTECTION, 2024    71

TABLE 5   NUMBER OF CLINICAL TRIALS, 2024      72

TABLE 6   NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                74

TABLE 7   EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75

TABLE 8   ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75

TABLE 9   LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                76

TABLE 10 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                76

TABLE 11 ANALYTICAL STANDARD MARKET: ROLE IN ECOSYSTEM        84

TABLE 12 ANALYTICAL STANDARDS MARKET: PORTER’S FIVE FORCES 85

TABLE 13 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 87

TABLE 14 KEY BUYING CRITERIA FOR ACCESSORIES AND CONSUMABLES                 88

TABLE 15 IMPORT DATA FOR HS CODE 293499, BY COUNTRY, 2019−2023 (USD)                 89

TABLE 16 EXPORT DATA FOR HS CODE 293499, BY COUNTRY, 2019−2023 (USD)                 89

TABLE 17 ANALYTICAL STANDARDS MARKET: LIST OF MAJOR PATENTS                 91

TABLE 18 AVERAGE SELLING PRICE OF ANALYTICAL STANDARDS, BY KEY PLAYER,

2024 (USD)              93

TABLE 19 AVERAGE SELLING PRICE TREND OF ANALYTICAL STANDARDS, BY REGION,

2022–2024            94

TABLE 20 ANALYTICAL STANDARDS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026              98

TABLE 21 ANALYTICAL STANDARDS MARKET: CURRENT UNMET NEEDS                 101

TABLE 22 ANALYTICAL STANDARDS MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION) 105

TABLE 23 SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)                 106

TABLE 24 SPECTROSCOPY MARKET, BY CATEGORY, 2022–2030 (USD MILLION)                 106

TABLE 25 SPECTROSCOPY MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 107

TABLE 26 SPECTROSCOPY MARKET, BY METHODOLOGY, 2022–2030 (USD MILLION) 107

TABLE 27 SPECTROSCOPY MARKET, BY REGION, 2022–2030 (USD MILLION)                 108

TABLE 28 NORTH AMERICA: SPECTROSCOPY MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   108

TABLE 29 EUROPE: SPECTROSCOPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 108

TABLE 30 ASIA PACIFIC: SPECTROSCOPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)         109

TABLE 31 LATIN AMERICA: SPECTROSCOPY MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   109

TABLE 32 MIDDLE EAST & AFRICA: SPECTROSCOPY MARKET, BY REGION,

2022–2030 (USD MILLION)   109

TABLE 33 MASS SPECTROSCOPY MARKET, BY REGION, 2022–2030 (USD MILLION) 110

TABLE 34 ATOMIC ABSORPTION SPECTROSCOPY MARKET, BY REGION,

2022–2030 (USD MILLION)   111

TABLE 35 UV/VISIBLE SPECTROSCOPY MARKET, BY REGION, 2022–2030 (USD MILLION) 111

TABLE 36 X-RAY FLUORESCENCE/DIFFRACTION SPECTROSCOPY MARKET, BY REGION, 2022–2030 (USD MILLION)     112

TABLE 37 IR SPECTROSCOPY MARKET, BY REGION, 2022–2030 (USD MILLION)                 113

TABLE 38 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY MARKET, BY REGION,

2022–2030 (USD MILLION)   113

TABLE 39 OTHER SPECTROSCOPY STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION) 114

TABLE 40 CHROMATOGRAPHY MARKET, BY TYPE, 2022–2030 (USD MILLION)                 115

TABLE 41 CHROMATOGRAPHY MARKET, BY CATEGORY, 2022–2030 (USD MILLION) 116

TABLE 42 CHROMATOGRAPHY MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 116

TABLE 43 CHROMATOGRAPHY MARKET, BY METHODOLOGY, 2022–2030 (USD MILLION) 117

TABLE 44 CHROMATOGRAPHY MARKET, BY REGION, 2022–2030 (USD MILLION)                 117

TABLE 45 NORTH AMERICA: CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   117

TABLE 46 EUROPE: CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)         118

TABLE 47 ASIA PACIFIC: CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   118

TABLE 48 LATIN AMERICA: CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   118

TABLE 49 MIDDLE EAST & AFRICA: CHROMATOGRAPHY MARKET, BY REGION,

2022–2030 (USD MILLION)   119

TABLE 50 ION CHROMATOGRAPHY MARKET, BY REGION, 2022–2030 (USD MILLION) 119

TABLE 51 GAS CHROMATOGRAPHY MARKET, BY REGION, 2022–2030 (USD MILLION) 120

TABLE 52 LIQUID CHROMATOGRAPHY MARKET, BY REGION, 2022–2030 (USD MILLION) 121

TABLE 53 THIN-LAYER CHROMATOGRAPHY MARKET, BY REGION, 2022–2030 (USD MILLION)         121

TABLE 54 OTHER CHROMATOGRAPHY STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   122

TABLE 55 TITRIMETRY MARKET, BY CATEGORY, 2022–2030 (USD MILLION)                 123

TABLE 56 TITRIMETRY MARKET, BY APPLICATION, 2022–2030 (USD MILLION)                 123

TABLE 57 TITRIMETRY MARKET, BY METHODOLOGY, 2022–2030 (USD MILLION)                 124

TABLE 58 TITRIMETRY MARKET, BY REGION, 2022–2030 (USD MILLION)                 124

TABLE 59 NORTH AMERICA: TITRIMETRY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)         124

TABLE 60 EUROPE: TITRIMETRY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 125

TABLE 61 ASIA PACIFIC: TITRIMETRY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 125

TABLE 62 LATIN AMERICA: TITRIMETRY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 126

TABLE 63 MIDDLE EAST & AFRICA: TITRIMETRY MARKET, BY REGION,

2022–2030 (USD MILLION)   126

TABLE 64 PHYSICAL PROPERTY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION) 127

TABLE 65 PHYSICAL PROPERTY TESTING MARKET, BY CATEGORY,

2022–2030 (USD MILLION)   127

TABLE 66 PHYSICAL PROPERTY TESTING MARKET, BY APPLICATION,

2022–2030 (USD MILLION)   128

TABLE 67 PHYSICAL PROPERTY TESTING MARKET, BY METHODOLOGY,

2022–2030 (USD MILLION)   128

TABLE 68 PHYSICAL PROPERTY TESTING MARKET, BY REGION, 2022–2030 (USD MILLION) 129

TABLE 69 NORTH AMERICA: PHYSICAL PROPERTY TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   129

TABLE 70 EUROPE: PHYSICAL PROPERTY TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   129

TABLE 71 ASIA PACIFIC: PHYSICAL PROPERTY TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   130

TABLE 72 LATIN AMERICA: PHYSICAL PROPERTY TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   130

TABLE 73 MIDDLE EAST & AFRICA: PHYSICAL PROPERTY TESTING MARKET, BY REGION, 2022–2030 (USD MILLION)     130

TABLE 74 VISCOSITY TESTING MARKET, BY REGION, 2022–2030 (USD MILLION)                 131

TABLE 75 SIEVE CALIBRATION & PARTICLE SIZE TESTING MARKET, BY REGION,

2022–2030 (USD MILLION)   132

TABLE 76 COLOR REFERENCE TESTING MARKET, BY REGION, 2022–2030 (USD MILLION) 132

TABLE 77 OTHER PHYSICAL PROPERTY TESTING STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   133

TABLE 78 ANALYTICAL STANDARDS MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 135

TABLE 79 ANALYTICAL STANDARDS MARKET: VOLUME DATA (THOUSAND UNITS)                 135

TABLE 80 PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   136

TABLE 81 PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   137

TABLE 82 NORTH AMERICA: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)             137

TABLE 83 EUROPE: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)  137

TABLE 84 ASIA PACIFIC: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)             138

TABLE 85 LATIN AMERICA: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)             138

TABLE 86 MIDDLE EAST & AFRICA: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)           138

TABLE 87 PHARMACOPOEIA STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         139

TABLE 88 PHARMACEUTICAL IMPURITY REFERENCE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)     140

TABLE 89 PHARMACEUTICAL SECONDARY STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   141

TABLE 90 HERBAL DRUG/PHYTOPHARMACEUTICAL STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)     142

TABLE 91 COSMETIC STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION) 143

TABLE 92 FLUORESCENT MICROPARTICLE STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   143

TABLE 93 FOOD & BEVERAGE STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION) 145

TABLE 94 FOOD & BEVERAGE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         145

TABLE 95 NORTH AMERICA: FOOD & BEVERAGE STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   146

TABLE 96 EUROPE: FOOD & BEVERAGE STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   146

TABLE 97 ASIA PACIFIC: FOOD & BEVERAGE STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   146

TABLE 98 LATIN AMERICA: FOOD & BEVERAGE STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   147

TABLE 99 MIDDLE EAST & AFRICA: FOOD & BEVERAGE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)     147

TABLE 100               PEPTIDE/AMINO ACID STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   148

TABLE 101               FLAVOR & FRAGRANCE STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   149

TABLE 102               MYCOTOXIN STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         149

TABLE 103               CARBOHYDRATE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               150

TABLE 104               FATTY ACID/LIPID STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               151

TABLE 105               FOOD ADDITIVE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               152

TABLE 106               PESTICIDE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         152

TABLE 107               GMO STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION) 153

TABLE 108              OTHER FOOD & BEVERAGE STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   154

TABLE 109               FORENSIC STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION) 154

TABLE 110               FORENSIC STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         155

TABLE 111               NORTH AMERICA: FORENSIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   155

TABLE 112               EUROPE: FORENSIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   155

TABLE 113               ASIA PACIFIC: FORENSIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   156

TABLE 114               LATIN AMERICA: FORENSIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   156

TABLE 115               MIDDLE EAST & AFRICA: FORENSIC STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   156

TABLE 116               DRUGS-OF-ABUSE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               157

TABLE 117               DOPING STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         158

TABLE 118               OTHER FORENSIC STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               158

TABLE 119               VETERINARY DRUG STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)               159

TABLE 120               VETERINARY DRUG STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)   159

TABLE 121               NORTH AMERICA: VETERINARY DRUG STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   160

TABLE 122               EUROPE: VETERINARY DRUG STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   160

TABLE 123               ASIA PACIFIC: VETERINARY DRUG STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   160

TABLE 124               LATIN AMERICA: VETERINARY DRUG STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   161

TABLE 125               MIDDLE EAST & AFRICA: VETERINARY DRUG STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)                161

TABLE 126               ANTIBIOTIC STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         162

TABLE 127               HORMONE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         162

TABLE 128               PETROCHEMICAL STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)               163

TABLE 129               PETROCHEMICAL STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               163

TABLE 130               NORTH AMERICA: PETROCHEMICAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   164

TABLE 131               EUROPE: PETROCHEMICAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   164

TABLE 132               ASIA PACIFIC: PETROCHEMICAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   164

TABLE 133               LATIN AMERICA: PETROCHEMICAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   165

TABLE 134               MIDDLE EAST & AFRICA: PETROCHEMICAL STANDARDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)             165

TABLE 135               GASOLINE, DIESEL, AND PETROLEUM STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   166

TABLE 136               BIOFUEL STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         166

TABLE 137               ENVIRONMENTAL STANDARDS APPLICATION MARKET, BY TYPE,

2022–2030 (USD MILLION)   167

TABLE 138               ENVIRONMENTAL STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               168

TABLE 139               NORTH AMERICA: ENVIRONMENTAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   168

TABLE 140               EUROPE: ENVIRONMENTAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   168

TABLE 141               ASIA PACIFIC: ENVIRONMENTAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   169

TABLE 142               LATIN AMERICA: ENVIRONMENTAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   169

TABLE 143               MIDDLE EAST & AFRICA: ENVIRONMENTAL STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)                169

TABLE 144               PESTICIDE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         170

TABLE 145               PFAS TESTING STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               171

TABLE 146               MICROPLASTIC TESTING STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   172

TABLE 147               VOLATILE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         172

TABLE 148               SEMI-VOLATILE STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)               173

TABLE 149               AROCLOR/PCB AND DIOXIN STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   174

TABLE 150               FLAME-RETARDANT STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   174

TABLE 151               OTHER ENVIRONMENTAL STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   175

TABLE 152               CLINICAL DIAGNOSTICS STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   176

TABLE 153               CLINICAL DIAGNOSTICS STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   176

TABLE 154               NORTH AMERICA: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)             176

TABLE 155               EUROPE: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   177

TABLE 156               ASIA PACIFIC: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   177

TABLE 157               LATIN AMERICA: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)             178

TABLE 158               MIDDLE EAST & AFRICA: CLINICAL DIAGNOSTICS STANDARDS MARKET,

BY REGION, 2022–2030 (USD MILLION)                178

TABLE 159               HORMONE TESTING STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   179

TABLE 160               VITAMIN STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         179

TABLE 161               BIOMARKER STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         180

TABLE 162               CLINICAL TOXICOLOGY STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   181

TABLE 163               OTHER CLINICAL DIAGNOSTICS STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   181

TABLE 164               ANALYTICAL STANDARDS MARKET, BY METHODOLOGY,

2022–2030 (USD MILLION)   183

TABLE 165               ANALYTICAL STANDARDS MARKET FOR RAW MATERIAL TESTING, BY REGION, 2022–2030 (USD MILLION)                184

TABLE 166               NORTH AMERICA: RAW MATERIAL TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   184

TABLE 167               EUROPE: RAW MATERIAL TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   184

TABLE 168               ASIA PACIFIC: RAW MATERIAL TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   185

TABLE 169               LATIN AMERICA: RAW MATERIAL TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   185

TABLE 170               MIDDLE EAST & AFRICA: RAW MATERIAL TESTING MARKET, BY REGION,

2022–2030 (USD MILLION)   185

TABLE 171               ANALYTICAL STANDARDS MARKET FOR STABILITY TESTING, BY REGION,

2022–2030 (USD MILLION)   186

TABLE 172               NORTH AMERICA: STABILITY TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   186

TABLE 173               EUROPE: STABILITY TESTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)               187

TABLE 174               ASIA PACIFIC: STABILITY TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   187

TABLE 175               LATIN AMERICA: STABILITY TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   187

TABLE 176               MIDDLE EAST & AFRICA: STABILITY TESTING MARKET, BY REGION,

2022–2030 (USD MILLION)   188

TABLE 177               ANALYTICAL STANDARDS MARKET FOR BIOANALYTICAL TESTING, BY REGION, 2022–2030 (USD MILLION)                188

TABLE 178               NORTH AMERICA: BIOANALYTICAL TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   189

TABLE 179               EUROPE: BIOANALYTICAL TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   189

TABLE 180               ASIA PACIFIC: BIOANALYTICAL TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   189

TABLE 181               LATIN AMERICA: BIOANALYTICAL TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   190

TABLE 182               MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING MARKET, BY REGION,

2022–2030 (USD MILLION)   190

TABLE 183               ANALYTICAL STANDARDS MARKET FOR DISSOLUTION TESTING, BY REGION,

2022–2030 (USD MILLION)   191

TABLE 184               NORTH AMERICA: DISSOLUTION TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   191

TABLE 185               EUROPE: DISSOLUTION TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   191

TABLE 186               ASIA PACIFIC: DISSOLUTION TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   192

TABLE 187               LATIN AMERICA: DISSOLUTION TESTING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   192

TABLE 188               MIDDLE EAST & AFRICA: DISSOLUTION TESTING MARKET, BY REGION,

2022–2030 (USD MILLION)   192

TABLE 189               ANALYTICAL STANDARDS MARKET FOR OTHER METHODOLOGIES, BY REGION, 2022–2030 (USD MILLION) 193

TABLE 190               NORTH AMERICA: OTHER METHODOLOGIES MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   193

TABLE 191               EUROPE: OTHER METHODOLOGIES MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   194

TABLE 192               ASIA PACIFIC: OTHER METHODOLOGIES MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   194

TABLE 193               LATIN AMERICA: OTHER METHODOLOGIES MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   195

TABLE 194               MIDDLE EAST & AFRICA: OTHER METHODOLOGIES MARKET, BY REGION,

2022–2030 (USD MILLION)   195

TABLE 195               ANALYTICAL STANDARDS MARKET, BY CATEGORY, 2022–2030 (USD MILLION)               197

TABLE 196               ORGANIC STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         198

TABLE 197               NORTH AMERICA: ORGANIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   199

TABLE 198               EUROPE: ORGANIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   199

TABLE 199               ASIA PACIFIC: ORGANIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   199

TABLE 200               LATIN AMERICA: ORGANIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   200

TABLE 201               MIDDLE EAST & AFRICA: ORGANIC STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   200

TABLE 202               INORGANIC STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         201

TABLE 203               NORTH AMERICA: INORGANIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   202

TABLE 204               EUROPE: INORGANIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   202

TABLE 205               ASIA PACIFIC: INORGANIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   202

TABLE 206               LATIN AMERICA: INORGANIC STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   203

TABLE 207               MIDDLE EAST & AFRICA: INORGANIC STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   203

TABLE 208               ANALYTICAL STANDARDS MARKET, BY REGION, 2022–2030 (USD MILLION)         205

TABLE 209               NORTH AMERICA: KEY MACROINDICATORS            206

TABLE 210               NORTH AMERICA: ANALYTICAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   207

TABLE 211               NORTH AMERICA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   208

TABLE 212               NORTH AMERICA: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   208

TABLE 213               NORTH AMERICA: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)               209

TABLE 214               NORTH AMERICA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   209

TABLE 215               NORTH AMERICA: ANALYTICAL STANDARDS MARKET, BY APPLICATION,

2022–2030 (USD MILLION)   210

TABLE 216               NORTH AMERICA: FOOD & BEVERAGE STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   210

TABLE 217               NORTH AMERICA: FORENSIC STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   211

TABLE 218               NORTH AMERICA: VETERINARY STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   211

TABLE 219               NORTH AMERICA: PETROCHEMICAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   211

TABLE 220               NORTH AMERICA: ENVIRONMENTAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   212

TABLE 221               NORTH AMERICA: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET,

BY TYPE, 2022–2030 (USD MILLION)    212

TABLE 222               NORTH AMERICA: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   213

TABLE 223               NORTH AMERICA: ANALYTICAL STANDARDS MARKET, BY METHODOLOGY,

2022–2030 (USD MILLION)   213

TABLE 224               NORTH AMERICA: ANALYTICAL STANDARDS MARKET, BY CATEGORY,

2022–2030 (USD MILLION)   213

TABLE 225               US: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   215

TABLE 226               US: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         215

TABLE 227               US: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION) 216

TABLE 228               US: PHYSICAL PROPERTY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)               216

TABLE 229               CANADA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   217

TABLE 230               CANADA: CHROMATOGRAPHY MARKET, BY TYPE, 2022–2030 (USD MILLION)               218

TABLE 231               CANADA: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         218

TABLE 232               CANADA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   219

TABLE 233               EUROPE: KEY MACROINDICATORS          220

TABLE 234               EUROPE: ANALYTICAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   221

TABLE 235               EUROPE: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   221

TABLE 236               EUROPE: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)               222

TABLE 237               EUROPE: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         222

TABLE 238               EUROPE: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   223

TABLE 239               EUROPE: ANALYTICAL STANDARDS MARKET, BY APPLICATION,

2022–2030 (USD MILLION)   223

TABLE 240               EUROPE: FOOD & BEVERAGE STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   224

TABLE 241               EUROPE: FORENSIC STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)               224

TABLE 242               EUROPE: VETERINARY STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)   224

TABLE 243               EUROPE: PETROCHEMICAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   225

TABLE 244               EUROPE: ENVIRONMENTAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   225

TABLE 245               EUROPE: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)     226

TABLE 246               EUROPE: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   226

TABLE 247               EUROPE: ANALYTICAL STANDARDS MARKET, BY METHODOLOGY,

2022–2030 (USD MILLION)   227

TABLE 248               EUROPE: ANALYTICAL STANDARDS MARKET, BY CATEGORY,

2022–2030 (USD MILLION)   227

TABLE 249               GERMANY: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   228

TABLE 250               GERMANY: CHROMATOGRAPHY MARKET, BY TYPE, 2022–2030 (USD MILLION)               229

TABLE 251               GERMANY: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         229

TABLE 252               GERMANY: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   230

TABLE 253               UK: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   231

TABLE 254               UK: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         231

TABLE 255               UK: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION) 232

TABLE 256               UK: PHYSICAL PROPERTY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)               232

TABLE 257               FRANCE: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   234

TABLE 258               FRANCE: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         234

TABLE 259               FRANCE: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         235

TABLE 260               FRANCE: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   235

TABLE 261               ITALY: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   236

TABLE 262               ITALY: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         236

TABLE 263               ITALY: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION) 237

TABLE 264               ITALY: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   237

TABLE 265               SPAIN: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   238

TABLE 266               SPAIN: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         239

TABLE 267               SPAIN: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION) 239

TABLE 268               SPAIN: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   240

TABLE 269               REST OF EUROPE: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   241

TABLE 270               REST OF EUROPE: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   241

TABLE 271               REST OF EUROPE: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)   242

TABLE 272               REST OF EUROPE: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   242

TABLE 273               ASIA PACIFIC: MACROECONOMIC INDICATORS       244

TABLE 274               ASIA PACIFIC: ANALYTICAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   246

TABLE 275               ASIA PACIFIC: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   246

TABLE 276               ASIA PACIFIC: CHROMATOGRAPHY MARKET, BY TYPE, 2022–2030 (USD MILLION)               247

TABLE 277               ASIA PACIFIC: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)               247

TABLE 278               ASIA PACIFIC: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   248

TABLE 279               ASIA PACIFIC: ANALYTICAL STANDARDS MARKET, BY APPLICATION,

2022–2030 (USD MILLION)   248

TABLE 280               ASIA PACIFIC: FOOD & BEVERAGE STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   249

TABLE 281               ASIA PACIFIC: FORENSIC STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   249

TABLE 282               ASIA PACIFIC: VETERINARY STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   249

TABLE 283               ASIA PACIFIC: PETROCHEMICAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   250

TABLE 284               ASIA PACIFIC: ENVIRONMENTAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   250

TABLE 285               ASIA PACIFIC: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)                251

TABLE 286               ASIA PACIFIC: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   251

TABLE 287               ASIA PACIFIC: ANALYTICAL STANDARDS MARKET, BY METHODOLOGY,

2022–2030 (USD MILLION)   252

TABLE 288               ASIA PACIFIC: ANALYTICAL STANDARDS MARKET, BY CATEGORY,

2022–2030 (USD MILLION)   252

TABLE 289               JAPAN: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   253

TABLE 290               JAPAN: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         253

TABLE 291               JAPAN: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         254

TABLE 292               JAPAN: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   254

TABLE 293               CHINA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   255

TABLE 294               CHINA: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         256

TABLE 295               CHINA: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         256

TABLE 296               CHINA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   257

TABLE 297               INDIA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   258

TABLE 298               INDIA: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         258

TABLE 299               INDIA: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION) 259

TABLE 300               INDIA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   259

TABLE 301               AUSTRALIA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   260

TABLE 302               AUSTRALIA: CHROMATOGRAPHY MARKET, BY TYPE, 2022–2030 (USD MILLION)               261

TABLE 303               AUSTRALIA: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         261

TABLE 304              AUSTRALIA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   262

TABLE 305               SOUTH KOREA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   263

TABLE 306               SOUTH KOREA: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   263

TABLE 307               SOUTH KOREA: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)               264

TABLE 308               SOUTH KOREA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   264

TABLE 309               REST OF ASIA PACIFIC: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   265

TABLE 310               REST OF ASIA PACIFIC: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   265

TABLE 311               REST OF ASIA PACIFIC: SPECTROSCOPY MARKET, BY TYPE,

2022–2030 (USD MILLION)   266

TABLE 312               REST OF ASIA PACIFIC: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   266

TABLE 313               LATIN AMERICA: KEY MACROINDICATORS              267

TABLE 314               LATIN AMERICA: ANALYTICAL STANDARDS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)   268

TABLE 315               LATIN AMERICA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   268

TABLE 316               LATIN AMERICA: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   269

TABLE 317               LATIN AMERICA: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)               269

TABLE 318               LATIN AMERICA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   270

TABLE 319               LATIN AMERICA: ANALYTICAL STANDARDS MARKET, BY APPLICATION,

2022–2030 (USD MILLION)   270

TABLE 320               LATIN AMERICA: FOOD & BEVERAGE STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   271

TABLE 321               LATIN AMERICA: FORENSIC STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   271

TABLE 322              LATIN AMERICA: VETERINARY STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   271

TABLE 323               LATIN AMERICA: PETROCHEMICAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   272

TABLE 324               LATIN AMERICA: ENVIRONMENTAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   272

TABLE 325               LATIN AMERICA: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET,

BY TYPE, 2022–2030 (USD MILLION)    273

TABLE 326               LATIN AMERICA: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   273

TABLE 327               LATIN AMERICA: ANALYTICAL STANDARDS MARKET, BY METHODOLOGY,

2022–2030 (USD MILLION)   274

TABLE 328               LATIN AMERICA: ANALYTICAL STANDARDS MARKET, BY CATEGORY,

2022–2030 (USD MILLION)   274

TABLE 329               BRAZIL: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   275

TABLE 330               BRAZIL: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         275

TABLE 331               BRAZIL: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         276

TABLE 332               BRAZIL: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   276

TABLE 333               MEXICO: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   277

TABLE 334               MEXICO: CHROMATOGRAPHY MARKET, BY TYPE,2022–2030 (USD MILLION)         278

TABLE 335               MEXICO: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)         278

TABLE 336               MEXICO: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   279

TABLE 337               REST OF LATIN AMERICA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)          279

TABLE 338               REST OF LATIN AMERICA: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   280

TABLE 339               REST OF LATIN AMERICA: SPECTROSCOPY MARKET, BY TYPE,

2022–2030 (USD MILLION)   280

TABLE 340               REST OF LATIN AMERICA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   281

TABLE 341               MIDDLE EAST & AFRICA: KEY MACROINDICATORS 282

TABLE 342               MIDDLE EAST & AFRICA: ANALYTICAL STANDARDS MARKET, BY REGION,

2022–2030 (USD MILLION)   282

TABLE 343               MIDDLE EAST & AFRICA: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)          282

TABLE 344               MIDDLE EAST & AFRICA: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   283

TABLE 345               MIDDLE EAST & AFRICA: SPECTROSCOPY MARKET, BY TYPE,

2022–2030 (USD MILLION)   283

TABLE 346               MIDDLE EAST & AFRICA: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   284

TABLE 347               MIDDLE EAST & AFRICA: ANALYTICAL STANDARDS MARKET, BY APPLICATION, 2022–2030 (USD MILLION)       284

TABLE 348               MIDDLE EAST & AFRICA: FOOD & BEVERAGE STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)     285

TABLE 349               MIDDLE EAST & AFRICA: FORENSIC STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   285

TABLE 350               MIDDLE EAST & AFRICA: VETERINARY STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   286

TABLE 351               MIDDLE EAST & AFRICA: PETROCHEMICAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   286

TABLE 352               MIDDLE EAST & AFRICA: ENVIRONMENTAL STANDARDS MARKET, BY TYPE,

2022–2030 (USD MILLION)   286

TABLE 353               MIDDLE EAST & AFRICA: PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)                287

TABLE 354               MIDDLE EAST & AFRICA: CLINICAL DIAGNOSTICS STANDARDS MARKET, BY TYPE, 2022–2030 (USD MILLION)     287

TABLE 355               MIDDLE EAST & AFRICA: ANALYTICAL STANDARDS MARKET, BY METHODOLOGY, 2022–2030 (USD MILLION)   288

TABLE 356               MIDDLE EAST & AFRICA: ANALYTICAL STANDARDS MARKET, BY CATEGORY,

2022–2030 (USD MILLION)   288

TABLE 357               GCC COUNTRIES: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)   289

TABLE 358               GCC COUNTRIES: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   289

TABLE 359               GCC COUNTRIES: SPECTROSCOPY MARKET, BY TYPE, 2022–2030 (USD MILLION)               290

TABLE 360               GCC COUNTRIES: PHYSICAL PROPERTY TESTING MARKET, BY TYPE,

2022–2030 (USD MILLION)   290

TABLE 361               REST OF MIDDLE EAST & AFRICA: ANALYTICAL STANDARDS MARKET,

BY TECHNIQUE, 2022–2030 (USD MILLION)          291

TABLE 362               REST OF MIDDLE EAST & AFRICA: CHROMATOGRAPHY MARKET, BY TYPE,

2022–2030 (USD MILLION)   291

TABLE 363               REST OF MIDDLE EAST & AFRICA: SPECTROSCOPY MARKET, BY TYPE,

2022–2030 (USD MILLION)   292

TABLE 364               REST OF MIDDLE EAST & AFRICA: PHYSICAL PROPERTY TESTING MARKET   292

TABLE 365               OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN

ANALYTICAL STANDARDS MARKET         294

TABLE 366               ANALYTICAL STANDARDS MARKET: DEGREE OF COMPETITION          296

TABLE 367               ANALYTICAL STANDARDS MARKET: REGION FOOTPRINT                 302

TABLE 368               ANALYTICAL STANDARDS MARKET: TECHNIQUE FOOTPRINT                 303

TABLE 369               ANALYTICAL STANDARDS MARKET: APPLICATION FOOTPRINT                 304

TABLE 370               ANALYTICAL STANDARDS MARKET: METHODOLOGY FOOTPRINT              305

TABLE 371               ANALYTICAL STANDARDS MARKET: CATEGORY FOOTPRINT                 306

TABLE 372               ANALYTICAL STANDARDS MARKET: DETAILED LIST OF KEY STARTUPS/SMES    309

TABLE 373               ANALYTICAL STANDARDS MARKET: COMPETITIVE BENCHMARKING

OF KEY EMERGING PLAYERS/STARTUPS                310

TABLE 374               ANALYTICAL STANDARDS MARKET: PRODUCT LAUNCHES,

JANUARY 2021–FEBRUARY 2025          313

TABLE 375               ANALYTICAL STANDARDS MARKET: DEALS, JANUARY 2021–FEBRUARY 2025     314

TABLE 376               ANALYTICAL STANDARDS MARKET: EXPANSIONS,

JANUARY 2021–FEBRUARY 2025          314

TABLE 377               MERCK KGAA: COMPANY OVERVIEW      316

TABLE 378               MERCK KGAA: PRODUCTS OFFERED      317

TABLE 379               MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2025     320

TABLE 380               MERCK KGAA: DEALS, JANUARY 2021−FEBRUARY 2025                 320

TABLE 381               MERCK KGAA: EXPANSIONS, JANUARY 2021−FEBRUARY 2025       320

TABLE 382               THE UNITED STATES PHARMACOPEIAL CONVENTION: COMPANY OVERVIEW              322

TABLE 383               THE UNITED STATES PHARMACOPEIAL CONVENTION: PRODUCTS OFFERED               323

TABLE 384               LGC LIMITED: COMPANY OVERVIEW       336

TABLE 385               LGC LIMITED: PRODUCTS OFFERED        337

TABLE 386               LGC LIMITED: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2025     338

TABLE 387               LGC LIMITED: DEALS, JANUARY 2021−FEBRUARY 2025                 339

TABLE 388               LGC LIMITED: EXPANSIONS, JANUARY 2021−FEBRUARY 2025       339

TABLE 389               AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW                 341

TABLE 390               AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED                 342

TABLE 391               AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021−FEBRUARY 2025          349

TABLE 392               AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021−FEBRUARY 2025          349

TABLE 393               WATERS CORPORATION: COMPANY OVERVIEW      351

TABLE 394               WATERS CORPORATION: PRODUCTS OFFERED      352

TABLE 395               WATERS CORPORATION: DEALS, JANUARY 2021−FEBRUARY 2025       355

TABLE 396               THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW                 357

TABLE 397               THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED                 358

TABLE 398               THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021−FEBRUARY 2025          359

TABLE 399               MALLINCKRODT: COMPANY OVERVIEW  360

TABLE 400               MALLINCKRODT: PRODUCTS OFFERED  362

TABLE 401               PERKINELMER: COMPANY OVERVIEW    363

TABLE 402               PERKINELMER: PRODUCTS OFFERED    363

TABLE 403               RESTEK CORPORATION: COMPANY OVERVIEW       364

TABLE 404               RESTEK CORPORATION: PRODUCTS OFFERED       364

TABLE 405               RESTEK CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2025          367

TABLE 406               SPEX CERTIPREP: COMPANY OVERVIEW 368

TABLE 407               SPEX CERTIPREP: PRODUCTS OFFERED 369

TABLE 408               ACCUSTANDARD INC.: COMPANY OVERVIEW          371

TABLE 409               ACCUSTANDARD: PRODUCTS OFFERED  371

TABLE 410               ACCUSTANDARD: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2025     372

TABLE 411               CAYMAN CHEMICAL: COMPANY OVERVIEW             374

TABLE 412               CAYMAN CHEMICAL: PRODUCTS OFFERED             374

TABLE 413               CAYMAN CHEMICAL: DEALS, JANUARY 2021−FEBRUARY 2025       375

TABLE 414               RICCA CHEMICAL COMPANY: COMPANY OVERVIEW                 376

TABLE 415               RICCA CHEMICAL COMPANY: PRODUCTS OFFERED                 376

TABLE 416               GFS CHEMICALS, INC.: COMPANY OVERVIEW         377

TABLE 417               GFS CHEMICALS, INC.: PRODUCTS OFFERED         377

TABLE 418               GFS CHEMICALS, INC.: DEALS, JANUARY 2021−FEBRUARY 2025       378

TABLE 419               CHIRON AS: COMPANY OVERVIEW          379

TABLE 420               CHIRON AS: PRODUCTS OFFERED           379

TABLE 421               CHIRON AS: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2025     383

TABLE 422               CHIRON AS: EXPANSIONS, JANUARY 2021−FEBRUARY 2025                 384

LIST OF FIGURES

FIGURE 1 MARKET SEGMENTATION        37

FIGURE 2 REGIONAL SEGMENTATION     38

FIGURE 3 RESEARCH DESIGN 41

FIGURE 4 ANALYTICAL STANDARDS MARKET: KEY DATA FROM PRIMARY SOURCES 44

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION            45

FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING             47

FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2023)                 49

FIGURE 8 ANALYTICAL STANDARDS MARKET: MARKET SIZE ESTIMATION METHODOLOGY       50

FIGURE 9 ANALYTICAL STANDARDS MARKET: TOP-DOWN APPROACH   50

FIGURE 10               ANALYTICAL STANDARDS MARKET: DATA TRIANGULATION                 53

FIGURE 11               ANALYTICAL STANDARDS MARKET, BY CATEGORY, 2024 VS. 2030 (USD MILLION)               56

FIGURE 12               ANALYTICAL STANDARDS MARKET, BY TECHNIQUE, 2024 VS. 2030 (USD MILLION)               57

FIGURE 13               ANALYTICAL STANDARDS MARKET, BY APPLICATION,

2024 VS. 2030 (USD MILLION)               58

FIGURE 14               ANALYTICAL STANDARDS MARKET, BY METHODOLOGY, 2024 VS. 2030 (%)            58

FIGURE 15               ANALYTICAL STANDARDS MARKET: REGIONAL SNAPSHOT                 59

FIGURE 16               STRINGENT REGULATORY GUIDELINES FOR PHARMACEUTICAL

AND FOOD & BEVERAGE INDUSTRIES TO PROPEL MARKET  60

FIGURE 17               PHARMACEUTICAL & LIFE SCIENCE STANDARDS MARKET, BY APPLICATION,

2024 VS. 2030 (USD MILLION)               61

FIGURE 18               PHARMACEUTICAL & LIFE SCIENCE STANDARDS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2023      62

FIGURE 19               CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD  63

FIGURE 20               NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023   63

FIGURE 21               ANALYTICAL STANDARDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES  64

FIGURE 22               R&D EXPENDITURE OF TOP PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2023−2024 (USD BILLION)  69

FIGURE 23               ANALYTICAL STANDARDS MARKET: VALUE CHAIN ANALYSIS                 81

FIGURE 24               ANALYTICAL STANDARDS MARKET: SUPPLY CHAIN ANALYSIS                 83

FIGURE 25               ANALYTICAL STANDARDS MARKET: ECOSYSTEM ANALYSIS                 84

FIGURE 26               ANALYTICAL STANDARDS MARKET: PORTER’S FIVE FORCES ANALYSIS 85

FIGURE 27               INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANALYTICAL STANDARDS        87

FIGURE 28               KEY BUYING CRITERIA FOR ANALYTICAL STANDARDS                 88

FIGURE 29               TOP PATENT OWNERS/PATENTING TRENDS FOR ANALYTICAL STANDARDS

IN LAST 12 YEARS   90

FIGURE 30               AVERAGE SELLING PRICE OF ANALYTICAL STANDARDS, BY APPLICATION,

2024 (USD)              92

FIGURE 31               AVERAGE SELLING PRICE OF ANALYTICAL STANDARDS, BY KEY PLAYER,

2024 (USD)              93

FIGURE 32               AVERAGE SELLING PRICE OF ANALYTICAL STANDARDS, BY REGION, 2024 (USD)               95

FIGURE 33               ANALYTICAL STANDARDS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES  99

FIGURE 34               ANALYTICAL STANDARDS MARKET: FUNDING & NUMBER OF DEALS,

BY KEY PLAYER, 2019–2023 (USD MILLION)         100

FIGURE 35               ANALYTICAL STANDARDS MARKET: NUMBER OF INVESTOR DEALS,

BY KEY PLAYER, 2019–2023 100

FIGURE 36               ANALYTICAL STANDARDS MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)            101

FIGURE 37               ANALYTICAL STANDARDS MARKET: IMPACT OF AI/GENERATIVE AI   103

FIGURE 38               NORTH AMERICA: ANALYTICAL STANDARDS MARKET SNAPSHOT               207

FIGURE 39               ASIA PACIFIC: ANALYTICAL STANDARDS MARKET SNAPSHOT                 245

FIGURE 40               REVENUE ANALYSIS OF KEY PLAYERS IN ANALYTICAL STANDARDS MARKET (2019–2023)      295

FIGURE 41               MARKET SHARE ANALYSIS OF KEY PLAYERS IN ANALYTICAL STANDARDS MARKET (2023) 296

FIGURE 42               ORGANIC ANALYTICAL STANDARDS MARKET RANKING, BY KEY PLAYER, 2023 297

FIGURE 43               INORGANIC ANALYTICAL STANDARDS MARKET RANKING, BY KEY PLAYER, 2023 298

FIGURE 44               ANALYTICAL STANDARDS MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023             300

FIGURE 45               ANALYTICAL STANDARDS MARKET: COMPANY FOOTPRINT                 301

FIGURE 46               ANALYTICAL STANDARDS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023          308

FIGURE 47               EV/EBITDA OF KEY VENDORS 311

FIGURE 48               YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS   311

FIGURE 49               ANALYTICAL STANDARDS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS         312

FIGURE 50               MERCK KGAA: COMPANY SNAPSHOT (2023)         317

FIGURE 51               THE UNITED STATES PHARMACOPEIAL CONVENTION: COMPANY SNAPSHOT (2023) 322

FIGURE 52               LGC LIMITED: COMPANY SNAPSHOT (2024)           337

FIGURE 53               AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)                 342

FIGURE 54               WATERS CORPORATION: COMPANY SNAPSHOT (2023)                 352

FIGURE 55               THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)     358

FIGURE 56               MALLINCKRODT: COMPANY SNAPSHOT (2023)     361